Complete remission of a metastatic neuroendocrine tumor of the pancreas with capecitabine (Xeloda) monotherapy.
Fürstenberger
Gregor
G
Tumor Center ZeTuP St.Gallen and Chur, Rorschacherstrasse 150, CH-9006 St Gallen, Switzerland. gfuerstenberger@sg.zetup.ch
Schmid
Peter
P
Duquesne
Ans
A
Ammann
Maria
M
Senn
Hans-Jörg
HJ
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000069287:Capecitabine; D053379:Chromogranin A / Q000097:blood; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005472:Fluorouracil / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed
D000964:Antimetabolites, Antineoplastic; D053379:Chromogranin A; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil